Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsQ32 Bio and Horizon Therapeutics plc announced that they have entered into a collaboration and option agreement to develop ADX-914 for the treatment of autoimmune diseases.
[Q32 Bio]
Home Newsletters Immune Regulation News Q32 Bio and Horizon Therapeutics Announce Collaboration in Autoimmune Diseases
